See. Treat. Cure.

Highly Specific Cancer Targeting

Using its proprietary platform technology, EM Imaging is developing a pipeline of highly novel in vivo c-Met targeting theragnostic and optical imaging agents that will alter the landscape of precision medicine.


EM Imaging has a portfolio of agents addressing a number of unmet medical needs


Ongoing Clinical Studies

EM Imaging is focused on the development of fluorescent optical imaging and therapeutic agents. Our current clinical trials are detailled in a dedicated section. 

Our Latest News